PATENT CLAIM ANALYSIS

Application Number: 16044217
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["424", "178100"]

Abstract:
The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.

Claim (Index 305):
The CTLA4-Ig composition of  claim 297 , wherein the CTLA4-Ig molecules are produced by a population of recombinant CHO cells.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 95.0
- Lexical Diversity: 1.85714
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12086786', '13796586', '12763902', '12251960', '13045335']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7155989413528869
- 35 USC 102 Novelty (BERT): 0.6173293257659018
- Combined Prediction Score: 0.7057719797941885
- Mean Citation Score: 330.338242
- Max Citation Score: 703.0169
- Similarity Product: 472.3470222405672

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test